Feb 12, 2023
Ultrasound 96 Probe Device Protocol for cancer cell treatment
- Aisling Field1,
- Brijeshtiwari 2,
- James F Curtin1,
- Julie Rose Mae Mondala1,
- Janith Wanigasekara1
- 1Technological University Dublin;
- 2Teagasc Food Research Centre Dublin
- Technological University Dublin
- TU Dublin
Protocol Citation: Aisling Field, Brijeshtiwari , James F Curtin, Julie Rose Mae Mondala, Janith Wanigasekara 2023. Ultrasound 96 Probe Device Protocol for cancer cell treatment. protocols.io https://dx.doi.org/10.17504/protocols.io.e6nvwkpdwvmk/v1
Manuscript citation:
Deprez, J., Lajoinie, G., Engelen, Y., De Smedt, S., & Lentacker, I. (2021). Opening doors with ultrasound and microbubbles: Beating biological barriers to promote drug delivery. Advanced Drug Delivery Reviews, 172, 9-36. doi: 10.1016/j.addr.2021.02.015. Pitt, W., Husseini, G., & Staples, B. (2004). Ultrasonic drug delivery – a general review. Expert Opinion On Drug Delivery, 1(1), 37-56. doi: 10.1517/17425247.1.1.37 Wanigasekara, J., de Carvalho, A., Cullen, P., Tiwari, B., & Curtin, J. (2021). Converging technologies: targeting the hallmarks of cancer using ultrasound and microbubbles. Trends In Cancer, 7(10), 886-890. doi: 10.1016/j.trecan.2021.07.004
License: This is an open access protocol distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited
Protocol status: Working
We use this protocol and it's working
Created: November 29, 2021
Last Modified: February 12, 2023
Protocol Integer ID: 55462
Keywords: Ultrasound, Cancer treatment, probe device protocol for cancer cell treatment ultrasound, cancer cell treatment ultrasound, cavitation activity, bubble with velocity, powerful ability of ultrasound, use of an ultrasound probe, ultrasound probe, ultrasound device, oscillating bubble, release of liposome, open liposome, ultrasound technique, cavitation, bubble, liposome, ultrasound, vesicle, filled bubble, ultrasonic transducer, ultrasonic liquid processor, gas bubble, short ultrasonic pulse, chemotherapeutic delivery, surrounding liquid, pressure wave, sound wave, novel technique in drug delivery benefit, shear rates proportional to the amplitude, high amplitudes the associated shear force
Abstract
Ultrasound is a sound wave with frequencies ranging between 20 kHz and 20 MHz. Ultrasound is able to temporarily and repeatedly open the BBB safely and enhance chemotherapeutic delivery without adverse effects.(Deprez et al., 2021). This novel technique in drug delivery benefits from the powerful ability of ultrasound to produce cavitation activity. Cavitation is the generation and activity of gas-filled bubbles in a medium exposed to ultrasound. As the pressure wave passes through the media, gas bubbles expand at low pressure and contract at high pressure. This leads to oscillation which produces a circulating fluid flow known as microstreaming around the bubble with velocities and shear rates proportional to the amplitude of the oscillation. At high amplitudes the associated shear forces can cut open liposomes (Wanigasekara et al., 2021; Deprez et al., 2021).
Vesicles denser than the surrounding liquid are drawn into the shear field surrounding an oscillating bubble. If the shear stress is greater than the strength of the vesicle, it will burst and spill its contents. In a liposome, the vesicle will reform, often at a smaller size than before meeting the shear field. Hence, some interior liquid must be released during the break down. (Pitt et al., 2004)
This protocol describes the use of an ultrasound probe to trigger the release of liposomes in glioblastoma cells. This method uses an ultrasound device which is set to the following parameters: Time = 3 min, Pulse = 59 /01, Amplitude = 20%. The ultrasound technique is an easy and reliable technique making it useful in the study of a variety of areas such as oncology. When applied to an ultrasonic transducer, the Pulser part of the instrument generates short, large amplitude electric pulses of controlled energy, which are transformed into short ultrasonic pulses.
The VCX 750 is the ultrasonic liquid processor used for this experiment. It is powerful and versatile and can process a wide range of sample types and volumes for many different applications.
Materials
- VCX 750 ultrasonic liquid processor
- 96 probe system
- 96 well plate
- retort stand
- laboratory Jack
- Sonics - Vibra cell power unit
- 96-well seed plate
- Nunclon™ Sphera™ 96-Well plate
- Incubator
- Fresh media
- Dimethyl sulfoxide (DMSO) (20%)
Troubleshooting
Safety warnings
- Laboratory coat and gloves must be worn at all times.
- Ear protection must be worn at all times due to the high- frequency sound level of the VCX 750 ultrasonic liquid processor.
- A safe distance must be kept between the operator and the VCX 750 ultrasonic liquid processor while in operation.
- Ensure there is signage advising others that an ultrasound device is in operation.
Before starting the ultrasound probe system, ensure that all parts of the system/device are free from mechanical damage and that the probe is connected tightly.
Image of the VCX 750 ultrasonic liquid processor
The 96-probe system is designed to fit perfectly into the 96 well plate, which can be used to grow and treat cancer cells. The retort stand is used to hold the Ultrasound 96 probe unit vertically. A laboratory Jack is used to hold the cancer cells grown in the 96 well plate and to move it towards the 96 probes.
A Sonics - Vibra cell power unit is needed to fix into ultrasound 96 probe. Using the power unit, the ultrasound treatment time (0 to 99 min), temperature, pulser, and amplitude can be controlled. Experiments found that the best parameters to use are 20% amplitude, Pulses of 59 seconds on and 1 second off with different time ranges (1, 3, 5, 10, and 20 min).
Data processor unit showing the experiment parameters
For 2D cell culture assays using a 96-well seed plate, seed cells in 100 μl of the appropriate media. For 3D cell culture assays using a Nunclon™ Sphera™ 96-Well plate, seed cells in 200 μl of the appropriate media. Leave 2D cells to adhere overnight at 37 ℃ in a humidified atmosphere at a density of 2 x 10^3 cells/well or 1 x 10^4 cells/well for 96 hours incubation time post-treatment and 24 hours incubation time post-treatment, respectively. During 3D cells, spheroids will usually form in 3-7 days from the starting date depending on seeding density.
On the day of ultrasound treatment, remove the culture media from the plates and add 100µl fresh media into each plate. It is Important that during ultrasound treatment all the 96 probe tips are immersed inside media/ any liquid). There mustn't be any empty wells, hence 100ul of media should be added into each well.
Ultrasound probe submerged in sample
Place the sample (plate without lid) in the centre of the laboratory Jack and slowly move into the 96 probe. 2mm distance must be kept from the bottom of the well to the probe tip during the treatment. After setting up the unit, the device is turned on. The samples are treated with the ultrasound using the parameters that were set.
Following treatment, remove the sample plates from the probe system and carry out post treatment incubation at 37 ℃ using 5% CO2. Dimethyl sulfoxide (DMSO) (20%) is used as a positive control. Ultrasound treated cells / tumorspheres are then used for further analysis.